Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.
- Bill Number
- H.Res. 732
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-09-17: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-04-08T15:31:14Z
AI-Generated Summary
Purpose
This House Resolution (H. Res. 732) expresses the U.S. House of Representatives' support for designating September 30, 2025, as "Rare Cancer Day." The goal is to highlight the unique challenges faced by patients with rare cancers, increase public and medical awareness of symptoms, and promote efforts to improve early diagnosis, treatment options, and survival rates.
Key Provisions
The resolution includes:
- Background facts ("Whereas" clauses): It notes that about 1 in 5 U.S. cancer patients has a rare cancer; all childhood cancers are considered rare; rare cancers account for 25% of annual cancer deaths; survival rates are lower for rare cancers compared to common ones; early detection is difficult due to unfamiliar symptoms and longer diagnosis times; greater awareness could lead to earlier detection and better outcomes; scientific knowledge and treatments for rare cancers lag behind those for common cancers; and treatment options are more limited.
- House actions ("Resolved" section): The House:
- Supports the "Rare Cancer Day" designation.
- Recognizes the prevalence and detection challenges of rare cancers.
- Acknowledges their impact on individuals and lower survival rates.
- Encourages awareness of symptoms to boost early detection.
- Promotes partnerships between medical, scientific, and other fields for better diagnosis and treatments.
- Supports funding for research into cures and treatments for rare cancers.
Significant Changes to Existing Law
This is a non-binding resolution, so it introduces no changes to existing laws or statutes. It serves as a symbolic expression of congressional support rather than enforceable legislation.
Potential Impacts
- On citizens: Could raise public awareness of rare cancer symptoms, potentially leading to earlier diagnoses and improved health outcomes for the estimated 1 in 5 cancer patients affected. It may empower patients and families by validating their challenges and encouraging advocacy.
- On government agencies: No direct mandates, but it signals congressional interest, which might influence future funding priorities at agencies like the National Institutes of Health (NIH) or Centers for Disease Control and Prevention (CDC) for rare cancer research.
- On international relations: Minimal impact, as it focuses on domestic awareness; however, it could indirectly support global health efforts by highlighting rare cancers, which affect populations worldwide.
- Overall, the resolution fosters a cultural shift toward prioritizing rare cancers without creating new obligations.
Main Stakeholders Affected
- Patients and families: Those with rare cancers (including all pediatric cancer patients) who face delayed diagnoses and limited treatments.
- Medical and scientific communities: Doctors, researchers, and clinicians who could benefit from increased awareness and partnerships to improve detection and develop therapies.
- Advocacy groups and nonprofits: Organizations focused on cancer research and patient support, which may use the resolution to amplify fundraising and policy efforts.
- Lawmakers and government: Members of Congress and health agencies, as it encourages funding and collaboration without imposing requirements.
Notable Legal, Constitutional, or Political Implications
- Legal: As a simple resolution, it requires only House approval and has no force of law, similar to other awareness designations (e.g., for diseases or observances). It does not create rights, obligations, or appropriations.
- Constitutional: Falls within Congress's broad authority under Article I to express opinions, recognize issues, and promote public welfare without infringing on other branches of government.
- Political: Demonstrates bipartisan support (introduced by representatives from both major parties), potentially building momentum for future legislation on cancer research funding. It underscores a non-partisan commitment to public health but carries no enforceable political weight beyond awareness-raising.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (4)
Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Dingell, Debbie [D-MI-6], Rep. McDonald Rivet, Kristen [D-MI-8]
Recent Actions
- 2025-09-17: Referred to the House Committee on Energy and Commerce.
- 2025-09-17: Submitted in House
- 2025-09-17: Submitted in House
Bill Versions
- Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment. — issued 2025-09-17 — PDF (3 pages)